A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization

American Journal of Cardiology

Volumn 79, Issue 1, 1997, Pages 58-63

  West, Jeffrey A ^a   Miller, Nancy H ^a   Parker, Kathleen M ^a   Senneca, Deborah ^a   Ghandour, Ghassan ^a   Clark, Mia ^a   Greenwald, George ^a   Heller, Robert S ^a   Fowler, Michael B ^a   DeBusk, Robert F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COUNSELING; FEASIBILITY STUDY; FORWARD HEART FAILURE; HEALTH MAINTENANCE ORGANIZATION; HOME CARE; HUMAN; MIDDLE AGED; PATIENT COMPLIANCE; TELEPHONE; UNITED STATES;

AGED; CALIFORNIA; CARDIAC OUTPUT, LOW; COUNSELING; FEASIBILITY STUDIES; HEALTH MAINTENANCE ORGANIZATIONS; HOME CARE SERVICES; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; TELEPHONE;

EID: 0030640868     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00676-5     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention. Mortality from congestive heart failure-United States, 1980-1990. MMWR Morb Mortal Weekly Rep 1994;43:77-81.
2. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-306.
3. HCIA Inc. and Ernst & Young LLP. The DRG Handbook. 1995:110.
4. Ghali JK, Cooper R, Ford E. Trends in hospitalization ratesfor heart failure in the United States, 1973-1986. Arch Intern Med 1990;150:769-773.
5. Stewart AL, Greenfield S, Hays RD, Wells KB, Rogers WH, Berry SD, McGlynn EA, Ware JE. Functional status and well-being of patients with chronic conditions results from the Medical Outcomes Study. JAMA 1989;262:907-913.
6. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 1991;325:303-310.
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
8. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
9. Bourassa MG, Gurné O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M, Johnstone DE, Yusuf S, for the SOLVD Investigators. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993;22(suppl A):14A-19A.
10. Rajfer SI. Perspective of the pharmaceutical industry on the development of new drugs for heart failure. J Am Coll Cardiol 1993;22(suppl A):198A-200A.
11. Peffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-677.
12. Pouleur H, Rousseau M, Oakley C, Ryden L, for the Xamoterol in Severe Heart Failure Study Group. Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol 1991;68:71-74.
13. Ghali JK, Kaclakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 1988;148:2013-2016.
14. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-1295.
15. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med 1984;100:258-268.
16. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994;154:433-437.
17. Kornowski R, Zeeli D, Averbuch M, Finkelstein A, Schwartz D, Moshkovitz M, Weinreb B, Hershkovitz R, Eyal D, Miller M, Levo Y, Pines A. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995;129:762-766.
18. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
19. DeBusk RF, Miller NH, Superko R, Dennis CA, Thomas RJ, Lew HT, Berger WE, Heller RS, Rompf J, Gee D, Kraemer H, Bandura A, Ghandour G, Clark M, Shah RV, Fisher L, Taylor CB. A case management system for coronary risk factor modification following acute myocardial infarction. Ann Intern Med 1994;120:721-729.
20. Williams JF, Bristow MR, Fowler MB, Francis GS, Garson A, Gersh BJ, Hammer DF, Hlatky MA, Leier S, Packer M, Rtt B, Ullyot DJ, Wexler LF, Winters WL. Guidelines for the evaluation and management of heart failure. Circulation 1995;92:2764-2784.
21. Konstam M, Dracup K, Baker DW, Bottorff MB, Brooks NH, Dacey R, Dunbar SB, Jackson AB, Jessup M, Johnson JC, Jones RH, Luchi RJ, Massie BM, Rtt B, Rose EA, Rubin LJ, Wright RF, Hadorn DC. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11. (AHCPR publication no. 94-0612). Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, June 1994.
22. Giles FD, Katz R, Sullivan JM, Wolfson P, Haugland J, Kirlin P, Powers E, Rich S, Hacksaw B, Chiaramida A, Rouleau JL, Fisher MB, Pigeon J, Rush JE, for the Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. J Am Coll Cardiol 1989;13:1240-1247.
23. Bandura A. Self-efficacy. In: Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall, 1986:393-398.
24. Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis. In: Diseases of the Heart and Blood Vessels 6th ed. Boston: Little, Brown, 1964:110-114.
25. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-654.
26. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
27. Taylor CB, Houston-Miller N, Killen JC, DeBusk R. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med 1990;113:118-123.
28. Perry HM, Sambhi MP, Cushman WC, Frieds ED, Rutan G, Bingham SF, Meyer G. The VA hypertension screening and treatment program. VA Practitioner 1992;November:54-60.
29. Peters AL, Davidson MB, Ossorio CR. Management of patients with diabetes by nurses with support of subspecialists. HMO Pract 1995;9:8-12.